Backed by market attractiveness analysis, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, wider supply chain intelligence, emerging startup coverage, and detailed product-level insights, The Business Research Company’s 2026 market reports are designed to offer research that is more actionable and strategically valuable than ever.
Sustained Release Excipients Market Size, Value And Growth Trajectory Through 2030
The sustained release excipients market size has experienced significant growth in recent years. It is forecast to increase from $1.51 billion in 2025 to $1.63 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical growth can be attributed to several factors, including the increasing prevalence of chronic diseases, a rise in the use of modified release tablets, developments in polymer chemistry, the expansion of generic drug manufacturing, and the regulatory acceptance of sustained release formulations.
The sustained release excipients market size is anticipated to experience substantial expansion in the coming years. This market is projected to reach $2.3 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.9%. Factors contributing to this expansion over the forecast period include the escalating demand for long-acting injectables, the expansion of biologics and specialty drugs, increased spending on drug delivery research and development, the need for patient-focused formulations, and the widening scope of pharmaceutical production in developing regions. Key trends emerging during this period encompass a growing desire for controlled drug delivery methods, the increased incorporation of polymers into sustained release compositions, the rising acceptance of oral sustained release dosage formats, advancements in microencapsulation and coacervation techniques, and an emphasis on improving patient adherence and minimizing dosage frequency.
Get A Free Sample Report With In-Depth Market Insights:
Sustained Release Excipients Market Growth Backed By Core Demand Fundamentals
The increasing demand for individualized medicine is anticipated to drive the expansion of the sustained-release excipients market in the future. Personalized medicine, also known as personalized care, involves healthcare providers examining patients’ distinct genes, proteins, and other physiological elements to deliver and manage tailored treatments through precision medicine. These sustained-release excipients are vital in personalized medicine, facilitating the creation of drug formulations specifically adapted for individual patient requirements. As an example, in February 2024, data from the Personalised Medicine Coalition, a US-based hospital and health care organization, indicated that in 2023, the FDA sanctioned 16 novel personalized treatments for patients with rare diseases, an increase from 6 in 2022. Consequently, the rising demand for personalized medicine is fueling the growth of the sustained-release excipients market.
Sustained Release Excipients Market Segment Performance And Emerging Opportunities
The sustained release excipients market covered in this report is segmented –
1) By Product: Gelatin, Polymers, Minerals, Chitosan
2) By Route of Administration: Oral, Intramuscular, Subcutaneous, Transdermal, Vaginal, Ophthalmic, Intravenous, Other Routes of Administration
3) By Technology: Targeted Delivery, Micro Encapsulation, Wurster Technique, Transdermal, Implants, Coacervation
Subsegments:
1) By Gelatin: Type A Gelatin, Type B Gelatin
2) By Polymers: Natural Polymers, Synthetic Polymers
3) By Minerals: Calcium Compounds, Magnesium Compounds, Other Mineral Excipients
4) By Chitosan: Low Molecular Weight Chitosan, High Molecular Weight Chitosan
Sustained Release Excipients Market Growth Trends Reshaping The Competitive Landscape
Leading companies in the sustained release excipients market are concentrating on developing sophisticated solutions, such as multifunctional polymer platforms, to improve drug formulation efficiency, reduce delivery durations, and enable precise controlled-release profiles. These multifunctional polymer platforms are excipients designed to facilitate immediate, delayed, and sustained drug release, and they are compatible with formulation techniques such as hot melt extrusion and solubility-enhancing spray drying. As an example, in September 2024, Evonik, a Germany-based company, initiated the operation of a new spray drying facility located at its Darmstadt site, specifically for EUDRAGIT polymers. This new facility boosts production capacity, shortens delivery periods, and is completely integrated into existing production systems. It utilizes green electricity and steam generated from local waste incineration, leading to an annual reduction of CO2 emissions by over 1,000 tons. The facility operates under IPEC-GMP pharmaceutical guidelines and is directly linked to the production of aqueous dispersions, thereby minimizing transportation needs and optimizing the supply chain. The polymers manufactured at this site facilitate immediate, delayed, and sustained release formulations, thereby solidifying Evonik’s position as a global center for oral drug delivery solutions and enhancing its capacity to efficiently back innovative pharmaceutical advancements.
Sustained Release Excipients Market Key Players: Which Companies Lead Industry Competition?
Major companies operating in the sustained release excipients market are BASF SE, Ashland Global Holdings Inc, Colorcon Inc, Evonik Industries AG, Lubrizol Corporation, Merck KGaA, Roquette Freres, Shin Etsu Chemical Co Ltd, JRS Pharma GmbH Co KG, SPI Pharma Inc, Croda International Plc, Lonza Group AG, Chemische Fabrik Budenheim KG, Asahi Kasei Corporation, DuPont de Nemours Inc, Dow Chemical Company, Eastman Chemical Company, Gattefosse SAS, Balchem Corporation, Associated British Foods plc, Ransom Naturals Ltd, Cellulose Solutions Private Limited
View The Full Sustained Release Excipients Market Report:
Sustained Release Excipients Market Geographic Spread And Regional Opportunities
North America was the largest region in the global sustained release excipients market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the sustained release excipients market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model